Jeffrey G. Gold
Director/Board Member bei Access Closure, Inc.
Profil
In addition to his role with Sapient, Mr. Gold holds five US patents and recently served as Executive Vice President & Chief Operating Officer, CardioThoracic Systems Inc. at Cupertino, CA.He is also a Venture Partner with Longitude Capital Management which he joined in 2006.
Prior to that, he was Chief Executive Officer of CryoVascular, a medical device company developing treatments for peripheral vascular disease, from 2001 to 2005.
CryoVascular was acquired by Boston Scientific Corporation in 2005.
Mr. Gold and Ms. Tammenoms Bakker worked together on the CryoVascular board of directors between 2000 and 2005.
Between 1997 and 2000, he was COO and Executive Vice President of CardioThoracic Systems, a medical device company focused on developing products to enable off-pump open-heart surgery.
CTSI completed an IPO in 1996 and was subsequently acquired by Guidant Corporation.
Prior to CTSI, Mr. Gold spent 18 years with Cordis Corporation, now the primary cardiovascular subsidiary of Johnson & Johnson.
He currently sits on the boards of Access Closure, AngioDynamics, Voyage Medical, and Niagara Gorge Medical Devices.
He also is a member of the Executive Committee of the Center for Entrepreneurship & Innovation at the University of Florida.
Mr. Gold holds an MBA from the University of Florida and a BS in Engineering from Northeastern University, and is a graduate of GE’s Manufacturing Management Program.
Aktive Positionen von Jeffrey G. Gold
| Unternehmen | Position | Beginn |
|---|---|---|
Sapient Capital Management LLC
 Sapient Capital Management LLC Investment ManagersFinance Founded by Mitchell Dann in 2000, Sapient Capital Management LLC is a venture capital firm located in Wilson, Wyoming | Corporate Officer/Principal | - |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jeffrey G. Gold
| Unternehmen | Position | Ende |
|---|---|---|
| ANGIODYNAMICS, INC. | Director/Board Member | 15.10.2019 |
Pacira CryoTech, Inc.
 Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Chief Executive Officer | 01.01.2016 |
Corindus, Inc.
 Corindus, Inc. Medical SpecialtiesHealth Technology Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters. | Director/Board Member | 12.08.2014 |
Velomedix, Inc.
 Velomedix, Inc. Medical SpecialtiesHealth Technology Velomedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury. A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death and preserves organ function. Therapeutic Hypothermia offers a novel solution for the protection of the body's organs during ischemic insults and later from reperfusion injury. Cooling protects tissue during ischemia by reducing oxygen metabolism, inflammation and maintaining cell membrane integrity. In the case of reperfusion injury hypothermia reduces oxidative stress, micro vascular clogging, free radical production and inflammatory responses which are destructive to cells that have had blood flow restored after a period of ischemia. | Chief Executive Officer | 01.03.2014 |
CryoVascular Systems, Inc.
 CryoVascular Systems, Inc. Pharmaceuticals: MajorHealth Technology Cryovascular Systems, Inc. used to develop therapy products for the treatment of peripheral vascular and cardiovascular diseases. The company products were includes non-saline angioplasty devices for arterial catheterization. Cryovascular Systems was founded by James Joye & Ronald Williams in 1977 and was headquartered in Los Gatos, CA | Chief Executive Officer | 01.01.2005 |
Ausbildung von Jeffrey G. Gold
| Northeastern University | Undergraduate Degree |
| University of Florida | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GE AEROSPACE | Producer Manufacturing |
| ANGIODYNAMICS, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
CardioThoracic Systems, Inc.
 CardioThoracic Systems, Inc. Miscellaneous Commercial ServicesCommercial Services CardioThoracic Systems, Inc., located in Cupertino, Calif., is a leading developer of proprietary technologies in minimally invasive cardiothoracic surgery. CTS introduced its first generation system for minimally invasive beating heart bypass surgery in January 1997. Since that time, over 11,000 beating heart bypass procedures, including midline and thorocotomy approaches, have been performed using CTS' propriety instruments. CTS is also developing technologies in the area of minimally invasive valve repair. CardioThoracic Systems, Inc., has been acquired by Guidant in 1999. | Commercial Services |
CryoVascular Systems, Inc.
CryoVascular Systems, Inc. Pharmaceuticals: MajorHealth Technology Cryovascular Systems, Inc. used to develop therapy products for the treatment of peripheral vascular and cardiovascular diseases. The company products were includes non-saline angioplasty devices for arterial catheterization. Cryovascular Systems was founded by James Joye & Ronald Williams in 1977 and was headquartered in Los Gatos, CA | Health Technology |
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Health Technology |
Pacira CryoTech, Inc.
Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Health Services |
Your Internet Defender, Inc.
 Your Internet Defender, Inc. Medical SpecialtiesHealth Technology Your Internet Defender, Inc. operates as a holding company with interests in vascular robotic assisted systems. The company through its subsidiary designs, manufactures and sell CorPath precision vascular robotic-assisted systems for use in interventional vascular procedures. Its flagship product, the CorPath Vascular Robotics System, brings the vascular robotic system to facilitate stent placement for percutaneous coronary intervention procedures performed in an interventional cath lab in which the physician uses a control panel console located within an interventional cockpit to measure, manipulate, and advance devices with robotic precision. The company was founded on May 4, 2011 and is headquartered in Waltham, MA. | Health Technology |
Sapient Capital Management LLC
Sapient Capital Management LLC Investment ManagersFinance Founded by Mitchell Dann in 2000, Sapient Capital Management LLC is a venture capital firm located in Wilson, Wyoming | Finance |
Corindus, Inc.
Corindus, Inc. Medical SpecialtiesHealth Technology Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters. | Health Technology |
Velomedix, Inc.
Velomedix, Inc. Medical SpecialtiesHealth Technology Velomedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury. A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death and preserves organ function. Therapeutic Hypothermia offers a novel solution for the protection of the body's organs during ischemic insults and later from reperfusion injury. Cooling protects tissue during ischemia by reducing oxygen metabolism, inflammation and maintaining cell membrane integrity. In the case of reperfusion injury hypothermia reduces oxidative stress, micro vascular clogging, free radical production and inflammatory responses which are destructive to cells that have had blood flow restored after a period of ischemia. | Health Technology |
| Cordis Endovascular Systems, Inc. | |
Corindus Vascular Robotics, Inc.
 Corindus Vascular Robotics, Inc. Medical SpecialtiesHealth Technology Corindus Vascular Robotics, Inc. engages in the provision of robotic-assisted vascular interventions. It provides CorPath platform for medical procedures. The company was founded by Tal Wenderow in 2002 and is headquartered in Waltham, MA. | Health Technology |
